Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous iron versus intravenous ascorbic acid in hemodialysis patients with functional iron deficiency
IRCT201112248501N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Jan 2012
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of Iron, ascorbic acid and erythropoietin in iron deficiency anemia (IDA) and Functional iron deficiency (FID) (2 arms), sponsored by Mazandaran University of Medical Sciences. Started Jan 2012; status: completed.
02
Drugs
Ironascorbic aciderythropoietin
03
Conditions
iron deficiency anemia (IDA)Functional iron deficiency (FID)
Beyond the preview
Go deeper on IRCT201112248501N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201112248501N1.